CervoMed is trading at $3.15 (+7.34%) in after-hours trading as broader markets strengthened after July PPI was flat, supporting expectations that the Federal Reserve may hold rates steady.
- No new company-specific announcement for August 13, 2026, was identified.
- Recent earnings and conference coverage remain the latest catalysts.
- The move likely reflects positive risk sentiment alongside the S&P 500’s +0.71% gain, rather than a fresh corporate event.